Blog  /  Laika Announcements

Congratulations to PharmaCCX on earning a SOC 2® Type 1 attestation

Pharmaccx SOC 2 T1

We are happy to announce that PharmaCCX, the leading provider of innovative access agreement infrastructure software, completed its SOC 2® Type 1 evaluation. Achieving SOC 2 demonstrates the company’s commitment to the industry’s highest standards for managing customer data.

By achieving SOC 2 Compliance, PharmaCCX clients (payers and pharmaceutical companies) in the healthcare space will benefit from added layers of trust including security, availability, processing, integrity, confidentiality, and privacy. 

The team at PharmaCCX worked closely with our compliance experts at Laika, Giselle Trivino, and Cristina Bartolacci, and completed their audit through Laika Compliance. 

“Our clients’ data is paramount, and that commitment to security is part of PhramaCCX’s DNA. SOC 2 report is a milestone that validates the intention we have put into designing our platform and procedures. Our clients need to trust that when they share data with us it will be handled in a safe and secure manner.”

Armen Solakhyan, Chief Technology Officer at PharmaCCX

“SOC 2 compliance is table stakes for vendors that want to build credibility with clients. PharmaCCX is creating an overall culture of compliance, exemplified by their commitment to SOC 2.”

Eva Pittas, founder and COO at Laika.

PharmaCCX has already begun work with Laika on its SOC 2 Type 2 examination and ISO 27001 certification, both of which PharmaCCX expects to complete in the next year.